- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01160965
Ropivacaine 0.75% Versus Levobupivacaine 0.5% for Conversion of Labour Epidural (RoLe)
December 28, 2011 updated by: Guy's and St Thomas' NHS Foundation Trust
Ropivacaine 0.75% Versus Levobupivacaine 0.5% for Conversion of Labour Epidural to Surgical Anaesthesia for Emergency Caesarean Section.
The aim of this trial is to compare the local anaesthetic ropivacaine to local anaesthetic levobupivacaine in converting the standard patient controlled labour epidural to provide anaesthesia for an emergency Caesarean section.
This is a technique commonly known as an epidural top-up.
The investigators set out to disprove the hypothesis that there is no difference between the 2 local anaesthetics in the time of onset and number of times epidural top-up needs supplementing during surgery.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Detailed Description
In a randomised controlled trial involving 45 patients the speed of onset of the effects of 20mls of 0.75% ropivacaine was found to be similar to that of 20mls of 0.5% bupivacaine1.
However it was also found to be more efficacious at preventing 'breakthrough' pain and therefore had a lower intra-operative supplementation rate.
Unfortunately the study was probably not powered adequately to confirm this finding.
Bupivacaine has now largely been replaced in the this field by the less cardio-toxic stereoisomer levobupivacaine.
A trial comparing 0.75% ropivacaine to 0.5% levobupivacaine and a lignocaine/adrenaline/fentanyl mixture was conducted in Singapore in 20082.
It did not show a clinical difference between any of the agents.
Whether the population studied is comparable to that in the UK is doubtful and it was not adequately powered to detect a difference in intra-operative supplementation rate.
Local experience has shown ropivacaine 0.75% to provide a block with a rapid onset that has little requirement for supplementation intra-operatively.
The need to supplement a local anaesthetic block during surgery means that the mother is experiencing a degree of pain that is unacceptable and we view this as a major consideration in choice of local anaesthetic for an epidural top-up.
Whilst speed of onset is important, in that it influences the decision to delivery time of the baby, the evaluation of intraoperative supplementation will be a major focus of this trial.
Study Type
Interventional
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
London, United Kingdom, SE1 7EH
- St Thomas' Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 46 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
Any subject requiring a grade 2 or 3 EmCS on the Hospital Birth Centre, St Thomas' who has:
- Labour analgesia provided by the standard patient controlled epidural (solution containing 0.1% levobupivacaine and 2mcg/ml fentanyl). That is providing analgesia via the patient controlled epidural analgesia infusion pump without the need for multiple extra boluses of epidural local anaesthetic and or opiates from the anaesthetist on the labour ward..
- Singleton pregnancy.
- Established labour, determined by the midwife responsible for the patient (usually by vaginal examination of the cervix).
- Gestation >36 weeks
- No complex past medical history according to the judgement of the investigator
- > 18 years of age
- EmCS starts between the hours 0800 and 1800.
- The ability to understand the patient information sheet and willing to provide informed consent.
- Had a minimal total dose of 50mcg of fentanyl since insertion of epidural
Exclusion Criteria:
- Pre-eclampsia / Eclampsia
- Antepartum haemorrhage
- Any congenital, structural or ischaemic heart disease.
- Category 1 EmCS.
- Participation in another therapeutic study in the last 12 weeks. -
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: 0.5% levobupivacaine
Participants given 15mls of 0.5% levobupivacaine as the solution for their epidural top-up
|
15mls of a 5mg/ml solution of the local anaesthetic levobupivacaine given via the epidural catheter.
Other Names:
|
|
Active Comparator: 0.75% Rpoivacaine
Participants given 15mls of 0.75% ropivacaine as the solution for their epidural top-up.
|
15mls of a 7.5mg/ml solution of the local anaesthetic ropivacaine given via the epidural catheter.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Supplementation Rate
Time Frame: During operation (approximately 1 hour )
|
The number of times the epidural anaesthetic requires intra-operative supplementation with more study solution or another drug for pain.
|
During operation (approximately 1 hour )
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pre-operative supplementation
Time Frame: 10-45mins (top-up to start of surgery)
|
If further 5mls of study solution is required to achieve block height suitable for surgery to start.
|
10-45mins (top-up to start of surgery)
|
|
Pain
Time Frame: During operation (approximately 1 hour)
|
Incidence of breakthrough pain and its intensity during the operative phase of the Caesarean section
|
During operation (approximately 1 hour)
|
|
Conversion Rate
Time Frame: At any point between epidural top-up and end of operation (approximately 90mins from epidural top-up)
|
If the epidural anaesthetic needs to be converted to spinal anaesthetic or general anaesthetic as it is not adequate for conduction of a Caesarean section
|
At any point between epidural top-up and end of operation (approximately 90mins from epidural top-up)
|
|
Side effects
Time Frame: At any point between top-up of epidural and end of operation (approximately 90mins from epidural top-up)
|
Occurrence of any of nausea, vomiting, itching and shivering during the specified time period
|
At any point between top-up of epidural and end of operation (approximately 90mins from epidural top-up)
|
|
Blood pressure supplementation rate
Time Frame: At any point from top-up of epidural to end of operation (approximately 90mins from epidural top-up)
|
Use of the vasopressor phenylephrine and Hartmannn's solution to be given if mean arterial BP drops greater than 30% below baseline or systolic BP of <100mg Hg.
|
At any point from top-up of epidural to end of operation (approximately 90mins from epidural top-up)
|
|
Patient Satisfaction
Time Frame: Prior to leaving operating theatre (approximatelty 120 minutes from epidural top-up)
|
Maternal satisfaction, asked to verbally score from 1-10 their satisfaction with the anaesthetic.
|
Prior to leaving operating theatre (approximatelty 120 minutes from epidural top-up)
|
|
Motor block
Time Frame: prior to top-up and prior to leaving theatre (approximatelty 120 minutes from epidural top-up).
|
Scored using the Bromage scoring system asking patient to raise legs and noting how able they are to do this.
|
prior to top-up and prior to leaving theatre (approximatelty 120 minutes from epidural top-up).
|
|
Fetal Wellbeing
Time Frame: After delivery (approximately 5-10 minutes from start of surgery)
|
Neonatal Apgar scores at 1 and 5 minutes after delivery.
pH of umbilical blood following delivery
|
After delivery (approximately 5-10 minutes from start of surgery)
|
|
Onset Time
Time Frame: From administration of epidural top-up (approximately 10-45 minutes)
|
The time elapsed between administration of the top-up and onset of anaesthesia suitable for surgery to proceed.
Defined as a loss of sensation to cold to T4 dermatomal level.
|
From administration of epidural top-up (approximately 10-45 minutes)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: geraldine e o'sullivan, MBBCh, Guy's and St Thomas' NHS Foundation Trust
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Sanders RD, Mallory S, Lucas DN, Chan T, Yeo S, Yentis SM. Extending low-dose epidural analgesia for emergency Caesarean section using ropivacaine 0.75%. Anaesthesia. 2004 Oct;59(10):988-92. doi: 10.1111/j.1365-2044.2004.03753.x.
- Sng BL, Pay LL, Sia AT. Comparison of 2% lignocaine with adrenaline and fentanyl, 0.75% ropivacaine and 0.5% levobupivacaine for extension of epidural analgesia for urgent caesarean section after low dose epidural infusion during labour. Anaesth Intensive Care. 2008 Sep;36(5):659-64. doi: 10.1177/0310057X0803600505.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2012
Primary Completion (Anticipated)
August 1, 2013
Study Completion (Anticipated)
August 1, 2014
Study Registration Dates
First Submitted
July 7, 2010
First Submitted That Met QC Criteria
July 12, 2010
First Posted (Estimate)
July 13, 2010
Study Record Updates
Last Update Posted (Estimate)
December 29, 2011
Last Update Submitted That Met QC Criteria
December 28, 2011
Last Verified
December 1, 2011
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- version1.0
- 2010-021783-15 (EudraCT Number)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Caesarean Section
-
Ashulia Women and Children HospitalCompleted
-
Assiut UniversityCompletedCaesarean SectionEgypt
-
Taipei Medical University WanFang HospitalCompletedCaesarean SectionTaiwan
-
South Tees Hospitals NHS Foundation TrustCompletedCaesarean Section | Caesarean Section; InfectionUnited Kingdom
-
Sichuan Provincial People's HospitalNot yet recruiting
-
Shanghai First Maternity and Infant HospitalUnknownCaesarean SectionChina
-
Karamanoğlu Mehmetbey UniversityRecruitingCaesarean SectionTurkey (Türkiye)
-
Büşra KüçüktürkmenNot yet recruiting
-
Maimonides Medical CenterTerminatedCaesarean SectionUnited States
Clinical Trials on 0.5% levobupivacaine
-
Duzce UniversityCompletedPain, Postoperative | Cholecystectomy, LaparoscopicTurkey
-
Balikesir UniversityCompleted
-
Cliniques universitaires Saint-Luc- Université...CompletedAnalgesia | Robotic SurgeryBelgium
-
Mahidol UniversityRamathibodi HospitalCompletedColorectal Cancer | Laparoscopic Colorectal SurgeryThailand
-
Cairo UniversityCompleted
-
Hospital Clínico Universitario de ValenciaRecruitingHip Fractures | Hemodynamic StabilitySpain
-
Balikesir UniversityCompleted
-
Chinese University of Hong KongRecruitingMusculoskeletal Diseases or ConditionsHong Kong
-
Pontificia Universidad Catolica de ChileUnknown
-
University Hospital, AntwerpCompletedOther Peripheral Nerve Disease